Niemann-Pick disease historical perspective: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Niemann-Pick disease}} {{CMG}} ==Overview== ==Historical Perspective== ==References== {{Reflist|2}} {{WH}} {{WS}}" |
No edit summary |
||
| Line 8: | Line 8: | ||
==Historical Perspective== | ==Historical Perspective== | ||
In 1914, A. Niemann reported an 18-month-old girl presented with progressive mental and motor deterioration with [[hepatosplenomegaly]] suggestive of type 2 [[Gaucher disease]]. In 1927, Ludwig Pick described the clinicopathologic features which helped differentiate these two disorders. In 1966, the defective enzyme was first identified by R. O. Brady at the [[National Institutes of Health]] (NIH). | |||
==References== | ==References== | ||
Revision as of 16:29, 7 November 2013
|
Niemann-Pick disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Niemann-Pick disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Niemann-Pick disease historical perspective |
|
Risk calculators and risk factors for Niemann-Pick disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
In 1914, A. Niemann reported an 18-month-old girl presented with progressive mental and motor deterioration with hepatosplenomegaly suggestive of type 2 Gaucher disease. In 1927, Ludwig Pick described the clinicopathologic features which helped differentiate these two disorders. In 1966, the defective enzyme was first identified by R. O. Brady at the National Institutes of Health (NIH).